Breast lumps secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{S.M}} | {{CMG}} {{AE}} {{S.M}} | ||
Secondary prevention of breast lumps is the same as primary prevention <ref name="pmid29284222">{{cite journal| author=Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B et al.| title=Primary and secondary prevention of breast cancer. | journal=Ann Agric Environ Med | year= 2017 | volume= 24 | issue= 4 | pages= 549-553 | pmid=29284222 | doi=10.26444/aaem/75943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29284222 }} </ref>. | Secondary prevention of [[breast lumps]] is the same as primary prevention <ref name="pmid29284222">{{cite journal| author=Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B et al.| title=Primary and secondary prevention of breast cancer. | journal=Ann Agric Environ Med | year= 2017 | volume= 24 | issue= 4 | pages= 549-553 | pmid=29284222 | doi=10.26444/aaem/75943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29284222 }} </ref>. | ||
*Surveillance and follow-up to reduce breast cancer | *Surveillance and follow-up to reduce breast cancer reccurance<ref name="pmid15459225">{{cite journal| author=de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ| title=Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 19 | pages= 4010-8 | pmid=15459225 | doi=10.1200/JCO.2004.06.080 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15459225 }} </ref> | ||
**History and clinical physical examination required every 4 to 6 months for 5 years | **History and clinical physical examination required every 4 to 6 months for 5 years | ||
**Annual mammography and clinical physical examination after first 5 years | **Annual [[mammography]] and clinical physical examination after first 5 years | ||
**Annual gynecological assessment for uterus evaluation for women on tamoxifen | **Annual gynecological assessment for uterus evaluation for women on [[tamoxifen]] | ||
**Bone health assessment for women on aromatase | **Bone health assessment for women on [[Aromatase inhibitor|aromatase inhibito]]<nowiki/>r and those who had [[ovarian failure]] secondary to treatment | ||
**Establishment of physical activity, alcohol intake, weight gain | **Establishment of physical activity, alcohol intake, weight gain | ||
Revision as of 20:55, 19 December 2018
|
Breast lumps Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Breast lumps secondary prevention On the Web |
|
American Roentgen Ray Society Images of Breast lumps secondary prevention |
|
Risk calculators and risk factors for Breast lumps secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Secondary prevention of breast lumps is the same as primary prevention [1].
- Surveillance and follow-up to reduce breast cancer reccurance[2]
- History and clinical physical examination required every 4 to 6 months for 5 years
- Annual mammography and clinical physical examination after first 5 years
- Annual gynecological assessment for uterus evaluation for women on tamoxifen
- Bone health assessment for women on aromatase inhibitor and those who had ovarian failure secondary to treatment
- Establishment of physical activity, alcohol intake, weight gain
References
- ↑ Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B; et al. (2017). "Primary and secondary prevention of breast cancer". Ann Agric Environ Med. 24 (4): 549–553. doi:10.26444/aaem/75943. PMID 29284222.
- ↑ de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004). "Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review". J Clin Oncol. 22 (19): 4010–8. doi:10.1200/JCO.2004.06.080. PMID 15459225.